| 1 |
35455642 | Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. | 2022 Mar 24 |
1 |
| 2 |
30091221 | PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin. | 2018 Oct |
1 |
| 3 |
17971810 | Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. | 2008 Jul |
1 |
| 4 |
18242899 | Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism. | 2008 May 22 |
2 |
| 5 |
17142564 | Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys. | 2007 Mar |
1 |
| 6 |
15158963 | Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. | 2004 Jun 11 |
2 |
| 7 |
14529371 | Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. | 2003 Oct |
2 |
| 8 |
10213372 | Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. | 1999 Mar |
1 |